Nutritional therapy in inflammatory bowel disease

Current Treatment Options in Gastroenterology

Volumn 7, Issue 3, 2004, Pages 191-198

  O'Sullivan, Maria ^a   O'Morain, Colm ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CORTICOSTEROID; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; STEROID;

CHILDHOOD DISEASE; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DIET; DIET THERAPY; DRUG MECHANISM; ELEMENTAL DIET; ENTERIC FEEDING; ENTERITIS; FAT INTAKE; GROWTH RETARDATION; HUMAN; LIFESTYLE; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; REVIEW; TOTAL PARENTERAL NUTRITION;

EID: 3142519921     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0040-2     Document Type: Review

References (38)

1. O'Morain C, Segal AW, Levi AJ: Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. BMJ 1984, 288:1859-1862.
2. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA: How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. J Parenter Enteral Nutr 1995, 19:356-364.
3. Messori A, Trallori G, D'Albasio G, et al.: Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol 1996, 31:267-272.
4. Teahon K, Bjarnason I, Pearson M, Levi AJ: Ten years' experience with an elemental diet in the management of Crohn's disease. Gut 1990, 31:1133-1137.
5. Fell JM, Paintin M, Arnaud-Battandier F, et al.: Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharm Ther 2000, 14:281-289.
6. O'Sullivan M, O'Morain C: Nutritional therapy in Crohn's disease. Inflamm Bowel Dis 1998, 4:45-53.
7. Akobeng AK, Miller V, Stanton J, et al.: Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000, 30:78-84.
8. Gassull MA, Fernandez-Banares F, Cabre E, et al.: Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002, 51:164-168.
9. Shanahan F: Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future. Br J Nutr 2002, 88(suppl 1):S5-S9.
10. Auvin S: Incidence, clinical presentation and localisation of pediatric inflammatory bowel disease at diagnosis in northern France (1998-99). Gut 2003, 35(suppl II):A53.
11. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ: Comprehensive nutritional status in patients with long-standing Crohn's disease currently in remission. Am J Clin Nutr 1998, 67:919-926.
12. Kyle UG, Pirlich M, Schuetz; T, et al.: Prevalence of malnutrition in hospitalized medical patients: impact of underlying disease. Dig Dis 2003, 21:245-251.
13. Gassull MA: Nutrition and inflammatory bowel disease: its relation to pathophysiology, outcome and therapy. Dig Dis 2003, 21:220-227.
14. Winter TA, Lemmer ER, O'Keefe SJ, Ogden JM: The effect of severe undernutrition, and subsequent refeeding on digestive function in human patients. Eur J Gastroenterol Hepatol 2000, 12:191-196.
15. Ballinger AB, Azooz O, El-Haj T, et al.: Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 2000, 46:694-700.
16. Tomer G, Ceballos C, Concepcion E, et al.: NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Am J Gastroenterol 2003, 98:2479-2484.
17. Wilschanski M, Sherman P, Pencharz P, et al.: Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 1996, 38:543-548.
18. Mahmud N, Weir DG: The urban diet and Crohn's disease: is there a relationship? Eur J Gastroenterol Hepatol, 2001, 13:93-95.
19. Greenberg GR, Fleming CR, Jeejeebhoy KN, et al.: Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut 1988, 29:1309-1315.
20. Bernstein CN, Papineau N, Zajaczkowski J, et al.: Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol 2000, 95:677-683.
21. O'Morain C, McGuinness A: Crohn's disease: enteral feeding. In Current Therapy in Gastroenterology and Liver Disease. St Louis: Mosby; 1994:278-281.
22. Teahon K, Pearson M, Levi AJ, et al.: Practical aspects of enteral nutrition in the management of Crohn's disease. J Parenter Enteral Nutr 1995, 19:365-368.
23. Mansfield JC, Giaffer MH, Holdsworth CD: Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease. Gut 1995, 36:60-66.
24. Lochs H, Steinhardt HJ, Klaus-Wentz B, et al.: Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV. Gastroenterology 1991, 101:881-888.
25. Bernstein CN, Leslie WD, Leboff MS: American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003, 124:791-794.
26. Scott EM, Gaywood I, Scott BB: Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 2000, 46(suppl 1):i1-i8.
27. van Staa TP, Cooper C, Brusse LS, et al.: Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003, 125:1591-1597.
28. Tamboli CP, Caucheteux C, Cortot A, et al.: Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol 2003, 17:805-820.
29. Floch MH: Probiotics, irritable bowel syndrome, and inflammatory bowel disease. Curr Treat Options Gastroenterol 2003, 6:283-288.
30. Stulnig TM: Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int Arch Allergy Immunol 2003, 132:310-321.
31. Belluzzi A, Brignola C, Campieri M, et al.: Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996, 334:1557-1560.
32. Belluzzi A, Boschi S, Brignola C, et al.: Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr 2000, 71(suppl 1):339S-342S.
33. Shimizu T, Fujii T, Suzuki R, et al.: Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 2003, 37:581-585.
34. Andoh A, Tsujikawa T, Ishizuka I, et al.: N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. Int J Mol Med 2003, 12:721-725.
35. Lomer MC, Harvey RS, Evans SM, et al.: Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. Eur J Gastroenterol Hepatol 2001, 13:101-106.
36. Lomer MC, Thompson RP, Powell JJ: Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc 2002, 61:123-130.
37. Siavoshian S, Segain JP, Kornprobst M, et al.: Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 2000, 47:397-403.
38. Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA: Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut 2003, 52:1442-1447.